Nutanix (NTNX) Tops Q3 EPS by 3c; Sales Beat

Nutanix (NASDAQ: NTNX) reported Q3 EPS of ($0.42), $0.03 better than the analyst estimate of ($0.45). Revenue for the quarter came in at $191.8 million versus the consensus estimate of $186.55 million.

• Revenue: $191.8 million, growing 67% year-over-year from $114.7 million in the third quarter of fiscal 2016
• Billings: $234.1 million, growing 47% year-over-year from $159.5 million in the third quarter of fiscal 2016
• Net Loss: GAAP net loss of $112.0 million, compared to a GAAP net loss of $46.8 million in the third quarter of fiscal 2016; Non-GAAP net loss of $60.8 million, compared to a non-GAAP net loss of $40.4 million in the third quarter of fiscal 2016
• Net Loss Per Share: GAAP net loss per share of $0.78, compared to a pro forma GAAP net loss per share of $0.39 in the third quarter of fiscal 2016; Non-GAAP net loss per share of $0.42, compared to a pro forma non-GAAP net loss per share of $0.33 in the third quarter of fiscal 2016
• Cash and Short-term Investments: $350.3 million, up 83% from the third quarter of fiscal 2016
• Deferred Revenue: $463.0 million, up 102% from the third quarter of fiscal 2016
• Operating Cash Flow: $(16.0) million, compared to $2.4 million in the third quarter of fiscal 2016, reflecting a $(9.6) million outflow of operating cash related to the purchase of ESPP shares
• Free Cash Flow: $(29.2) million, compared to $(11.0) million in the third quarter of fiscal 2016, also reflecting a $(9.6) million outflow of operating cash related to the purchase of ESPP shares

GUIDANCE:

Nutanix sees Q4 2017 EPS of ($0.38)-($0.39). Nutanix sees Q4 2017 revenue of $215-220 million, versus the consensus of $204.72 million.

For earnings history and earnings-related data on Nutanix (NTNX) click here.

You May Also Be Interested In

• IBM tumbles on soft Q1 revenue; announces HashiCorp $6.4bn acquisition
• Sanofi (SNY) Tops Q1 EPS by 85c; reaffirms guidance
• ATN International (ATNI) Misses Q1 EPS by 46c ; Offers Guidance